ArticleEuropean journal of nuclear medicine and molecular imaging2017
Pretreatment tumor SUV
Article in European journal of nuclear medicine and molecular imaging, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 3 syntheses or guidelines pooled it, 32 citations in OpenAlex.
- Prognostic significance ofCancer imaging : the official publication of the International Cancer Imaging Society · 2025Pooled it
- Global frequency and distribution of head and neck sarcomas in adulthood: a systematic review.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2024Pooled it
- Prognostic value of 18F-FDG PET-CT-based functional parameters in patients with soft tissue sarcoma: A meta-analysis.Medicine · 2017Pooled it
- Surgery confers survival benefit in De Novo metastatic soft tissue sarcoma patients with low Ki67 or low total lesion glycolysis: a combined PET/CT and clinicopathological analysis.European radiology · 2026Article
- [European journal of nuclear medicine and molecular imaging · 2026Article
- Texture analysis and metabolic parameters ofEuropean journal of nuclear medicine and molecular imaging · 2025Article
- [Scientific reports · 2023Article
- Comparison ofDiagnostics (Basel, Switzerland) · 2023Article
- A convolutional neural network with self-attention for fully automated metabolic tumor volume delineation of head and neck cancer inEuropean journal of nuclear medicine and molecular imaging · 2023Article
- Head-to-head evaluation of [European journal of nuclear medicine and molecular imaging · 2022Article
- Association between tumorScientific reports · 2022Article
- Virtual Biopsy in Soft Tissue Sarcoma. How Close Are We?Frontiers in oncology · 2022Review
- Review
- When SUV Matters: FDG PET/CT at Baseline Correlates with Survival in Soft Tissue and Ewing Sarcoma.Life (Basel, Switzerland) · 2021Article
- Primary tumor standardized uptake value (SUVmax) measured onJournal of cancer research and clinical oncology · 2020Article
- Comparison of diagnostic sensitivity of [EJNMMI research · 2020Article
- Pre-treatment metabolic tumor volume predicts tumor metastasis and progression in high-grade salivary gland carcinoma.Journal of cancer research and clinical oncology · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeHead and neck soft tissue sarcoma (HNSTS) is a rare type of tumor with various histological presentations and clinical behaviors.
methodsThis study included 36 consecutive patients with HNSTS who underwent
resultsUnivariate analyses showed that SUV
conclusionQuantitative metabolic measurements on pretreatment
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.